1. 国立がん研究センターがん情報サービス「がん登録・統計」 年齢階級別累積罹患リスク 2015 年 全部位. (Accessed March 10th, 2021, at https://ganjoho.jp/reg_stat/statistics/stat/summary.html.)
2. Nakata K, Ito Y, Magadi W, et al. Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010). Cancer Sci 2018;109:422-34.
3. Adolescent and Young Adult Oncology Progress Review Group (2006) Closing the Gap: research and cancer care imperatives for adolescents and youg adults with cancer. 2006. (Accessed 18th Februray, 2019, at https://www.livestrong.org/sites/default/files/what-we- do/reports/AYAO_PRG_Report_2006_FINAL.pdf.)
4. がん対策推進基本計画(第3期)平成30年3月. at http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000183313.html.)
5. Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, Japan (Ministry of Health, Labour and Welfare, National Cancer Registry). 2017.
6. Leading causes of death by sex and age (5-year age groups):Japan, 2019 (deaths, death rates (per 100,000 population), proportion(%)). 17th September, 2020 ed: Ministry of Health Labour and Welfare; 2019.
7. Cancer Registry and Statistics. Cancer Information Service NCC, Japan (Vital Statistics of Japan). 2019.
8. 全国がんセンター協議会の生存率共同調査(2020年11月集計)による. 2020.
9. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013;48:452-8.
10. 国立がん研究センターがん情報サービス「がん登録・統計」(全国がん登録) 2017.
11. Cancer Stat Facts: Cancer Among Adolescents and Young Adults (AYAs) (Ages 15– 39). (Accessed March, 8th, 2021, at https://seer.cancer.gov/statfacts/html/aya.html.)
12. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2020. (Accessed March 8th, 2021, at https://gco.iarc.fr/today.)
13. 国立成育医療研究センター小児がんセンター,国立がん研究センターがん対策情報センターがん登録センター. がん診療連携拠点病院等院内がん登録 2016 ー 2017 年小児 AYA 集計報告書. 2019.
14. 「総合的な思春期・若年成人(AYA)世代のがん対策のあり方に関する研究」班 編 AYA 世代がんサポートガイド: 金原出版; 2018.
15. 国立がん研究センターがん情報サービス「がん登録・統計」(全国がん罹患モニタリング集計(MCIJ)) 地域がん登録全国推計値(1975-2015). (Accessed March 8th, 2021, at https://ganjoho.jp/reg_stat/statistics/dl/index.html.)
16. Scheurer ME BMaGJ. Epidemiology of Childhood Cancer. In: DG PPaP, ed. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia: Lippinncott Wiliams &Wilkins 2011:2- 16.
17. Katanoda K, Shibata A, Matsuda T, et al. Childhood, adolescent and young adult cancer incidence in Japan in 2009-2011. Jpn J Clin Oncol 2017;47:762-71.
18. Part I General Features of Brain Tumors. Neurologia 2009;49:S1-25.
19. 大津留 悟、緑川 早苗、坂井 晃、志村 浩巳、鈴木 悟. 甲状腺がんと放射線障害. 日本内科学会誌 2015;104:593-9.
20. Ohira T, Shimura H, Hayashi F, et al. Absorbed radiation doses in the thyroid as estimated by UNSCEAR and subsequent risk of childhood thyroid cancer following the Great East Japan Earthquake. Journal of radiation research 2020;61:243-8.
21. がん診療拠点病院全国集計. 国立がん研究センター がん情報サービス, 2007-2015. (Accessed March 18th, 2021, at https://ganjoho.jp/reg_stat/statistics/brochure/hosp_c_registry.html.)
22. 国立がん研究センターがん情報サービス「院内がん登録全国集計」. 2016.
23. Andrew J. Stephenson TDG. Neoplasms of the Testis. In: Wein AJ, ed. Campbell- Walsh Urology. 10th ed. Philadelphia: ELSEVIER; 2012:837-70.
24. Bleyer BH-LaA. Testicular Cancer. In: Archie Bleyer RB, Lynn Ries, Jeremy Whelan, Andrea Ferrari, ed. Cancer in Adolescents and Young Adults. 2 ed. Switzerland: Springer International; 2017:307-18.
25. Oosterhuis JW, Looijenga LHJ. Human germ cell tumours from a developmental perspective. Nature reviews Cancer 2019;19:522-37.
26. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nature reviews Cancer 2005;5:210-22.
27. Cools M, Wolffenbuttel KP, Drop SL, Oosterhuis JW, Looijenga LH. Gonadal development and tumor formation at the crossroads of male and female sex determination. Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2011;5:167-80.
28. Bosch F. X dSS. Chapter 1: human papillomavirus and cervical cancer- burden and assessment of causality. J Natl Cancer Inst Monogr 2003;31:3-13.
29. Castle PE, Fetterman B, Akhtar I, et al. Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecologic oncology 2009;114:365-9.
30. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. The Journal of infectious diseases 1999;180:1415-23.
31. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. The New England journal of medicine 2007;356:1915-27.
32. Paavonen J, Naud P, Salmerón J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301-14.
33. 子宮頸がん予防についての正しい理解のために Part1 子宮頸がんと HPV ワクチンに関する最新の知識. (Accessed March 18th, 2021, at http://www.jsog.or.jp/uploads/files/jsogpolicy/HPV_Part1_3.1.pdf.)
34. Nakagawa S, Ueda Y, Yagi A, Ikeda S, Hiramatsu K, Kimura T. Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan. Cancer Sci 2020;111:2156-62.
35. Committee JSoHaNCCR. Report of Head and Neck Cancer Registry of Japan Clinical Statistics of Registered Patients2011.
36. 国立がん研究センターがん情報サービス「院内がん登録全国集計」. 2016-2017.
37. Kono Y, Kanzaki H, Iwamuro M, Kawano S, Kawahara Y, Okada H. Reality of Gastric Cancer in Young Patients: The Importance and Difficulty of the Early Diagnosis, Prevention and Treatment. Acta Med Okayama 2020;74:461-6.
38. Bleyer A. Other Carcinomas. In: Archie Bleyer AF, Jeremy Whelan, Ronald Barr, ed. Cancer in Adolescents and Young Adults. 2nd ed. Switzerland: Springer International; 2017:477- 507.
39. Kono Y, Kanzaki H, Tsuzuki T, et al. A multicenter observational study on the clinicopathological features of gastric cancer in young patients. J Gastroenterol 2019;54:419-26.
40. Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B. The distinctive biology of cancer in adolescents and young adults. Nature reviews Cancer 2008;8:288-98.
41. Macaron C, Leach BH, Burke CA. Hereditary colorectal cancer syndromes and genetic testing. Journal of surgical oncology 2015;111:103-11.
42. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America 1971;68:820-3.
43. 遺伝性大腸癌診療ガイドライン 2020 年版: 金原出版; 2020.
44. Asaka S, Arai Y, Nishimura Y, et al. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B. Carcinogenesis 2009;30:494-9.
45. Ishikubo T, Nishimura Y, Yamaguchi K, et al. The clinical features of rectal cancers with high-frequency microsatellite instability (MSI-H) in Japanese males. Cancer letters 2004;216:55-62.
46. Kneuertz PJ, Chang GJ, Hu CY, et al. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA surgery 2015;150:402-9.
47. 厚生労働省 国民生活基礎調査. 2019.
48. 厚生労働省. 厚生労働省:厚生労働科学研究費補助金(がん対策推進総合研究事業)「総合的な思春期・若年成人(AYA)世代のがん対策のあり方に関する研究」(研究代表者:堀部敬三,研究分担者:松本公一).分担研究報告書. 2017.